广发中证香港创新药ETF(QDII)(513120)资产配置
序号 |
报告期 |
股票占净比(%) |
债券占净比(%) |
现金占净比(%) |
净资产(元) |
1 |
2025-03-31 |
100.01 |
- |
5.24 |
10,456,401,270.03 |
2 |
2024-12-31 |
97.28 |
- |
6.25 |
7,875,258,558.68 |
3 |
2024-09-30 |
97.22 |
- |
4.55 |
6,812,388,095.83 |
4 |
2024-06-30 |
97.79 |
- |
3.11 |
4,955,210,534.97 |
5 |
2024-03-31 |
97.76 |
- |
3.80 |
5,758,429,931.05 |
6 |
2023-12-31 |
98.80 |
- |
2.96 |
6,780,707,589.67 |
7 |
2023-09-30 |
98.07 |
- |
3.23 |
4,066,157,064.90 |
8 |
2023-06-30 |
98.17 |
- |
2.83 |
2,484,392,013.82 |
9 |
2023-03-31 |
97.69 |
- |
3.96 |
512,400,570.93 |
10 |
2022-12-31 |
98.69 |
- |
1.39 |
184,877,452.08 |
11 |
2022-09-30 |
98.58 |
- |
1.31 |
109,051,587.08 |